Quantitative Microbial Risk Assessment of Pharmaceutical Products

Reference

1. 1.↵
   1. Clontz L.

   Microbial Limit and Bioburden Tests: Validation Approaches and Global Requirements, 2nd ed.; CRC Press: Boca Raton, FL: 2009.
2. 2.↵
   1. Jimenez L.

   Microbial Diversity in Pharmaceutical Product Recalls and Environments. PDA J. Pharm. Sci. Technol. 2007, 61(5), 383–399.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Sutton S.,
   2. Jimenez L.

   A Review of Reported Recalls Involving Microbiological Control 2004-2011 with Emphasis on FDA Considerations of Objectionable Organisms. Am. Pharm. Rev. 2012, 15(1), 42–57.

   OpenUrl
4. 4.↵
   1. Oxborrow G. S.,
   2. Roark A. L.,
   3. Fields N. D.,
   4. Puleo J. R.

   Mathematical Estimation of the Level of Microbial Contamination on Spacecraft Surfaces by Volumetric Air Sampling. Appl. Microbiol. 1974, 27(4), 706–712.

   OpenUrlPubMed
5. 5.↵
   1. Cassells A.

   Pathogen and Microbial Contamination Management in Micropropagation;Kluwer Academic Publishers: Dordrecht; 1997.
6. 6.↵
   <71> Sterility Tests. United States Pharmacopeia, 32; The United States Pharmacopeial Convention; Rockville, MD, 2009; pp 80–86.
7. 7.↵
   <1111> Microbiological Examination Of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use. United States Pharmacopeia 34/National Formulary 29; United States Pharmacopeial Convention, 2011; pp 630–631.
8. 8.↵
   1. Ouédraogo A.,
   2. Groso A.,
   3. Meyer T.

   Risk Analysis in Research Environment—Part I: Modeling Lab Criticity Index Using Improved Risk Priority Number. Safety Science 2011, 49(6), 778–784.

   OpenUrl
9. 9.↵
   1. Xiao N.,
   2. Huang H.,
   3. Li Y.,
   4. He L.,
   5. Jin T.

   Multiple Failure Modes Analysis and Weighted Risk Priority Number Evaluation in FMEA. Engineering Failure Analysis 2011, 18(4), 1162–1170.

   OpenUrl
10. 10.↵
    1. Hazlett L. D.,
    2. Rosen D. D.,
    3. Berk R. S.

    Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity 1978, 20(1), 25–29.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    Dose response assessment—QMRAwiki. http://qmrawiki.canr.msu.edu/index.php?title=Dose_response_assessment (accessed Jul 2, 2016).
12. 12.↵
    1. Sandle T.

    Pharmaceutical Microbiology: Essentials for Quality Assurance and Quality Control; Woodhead Publishing, Elsevier: Cambridge, 2015.
13. 13.↵
    1. Frost J.

    Understanding and Using Discrete Distributions | Minitab. http://blog.minitab.com/blog/adventures-in-statistics/understanding-and-using-discrete-distributions (accessed July 2, 2016).
14. 14.↵
    1. Knudsen L. F.

    Sample Size of Parenteral Solutions for Sterility Testing. J. Am. Pharm. Assoc. Am. Pharm. Assoc. 1949, 38(6), 332–337.

    OpenUrl
15. 15.↵
    1. Sutton S.

    The Sterility Tests. Rapid Sterility Testing; PDA/DHI Publishing: Bethesda, MD; 2011, pp 7–24.
16. 16.↵
    A2LA, G108—Guidelines for Estimating Uncertainty for Microbiological Counting Methods. https://www.a2la.org/guidance/mu_for_micro_labs.pdf (accessed July 2, 2016).
17. 17.↵
    1. Oliver J. D.

    The Viable but Non-Culturable State in Bacteria. J. Microbiol. 2005, 43(1), 93–100.

    OpenUrlPubMedWeb of Science
18. 18.↵
    Minitab reference manual; Minitab, Inc.: State College, PA, 1996.